By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Sigma-Aldrich today said that it has licensed worldwide rights to Kyoto University's induced pluripotent stem cell patent portfolio.

Under terms of the deal, iPS Academia Japan, which managed the patents and technology arising from Shinya Yamanaka's research at Kyoto University, will receive a license fee from Sigma-Aldrich. Financial and other terms of the license were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: the Human Silencing Hub protein complex, and more.

Heads of various research funding agencies discuss how to encourage scientific breakthroughs, ScienceInsider reports.

The Kansas City Star examines issues surrounding newborn genome sequencing.

Researchers say their Research Resource Identifier citation format is catching on, Nature News reports.